Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sweet Dream Oral Liquid in male schizophrenia patients on long-term atypical antipsychotics
ChiCTR2200063269Phase 4Recruiting
- Sponsor
- Wuhan Mental Health Center
- Start
- Aug 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Tianmeng Oral Liquid in schizophrenia, antipsychotic-induced hyperprolactinemia and sexual dysfunction (2 arms), sponsored by Wuhan Mental Health Center. Primary endpoints: Serum prolactin, Serum testosterone and 1 more. Started Aug 2022; status: recruiting.
02
Drugs
Tianmeng Oral Liquid
03
Conditions
schizophreniaantipsychotic-induced hyperprolactinemiasexual dysfunction
Beyond the preview
Go deeper on ChiCTR2200063269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063269.